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Reply
The issues surrounding the role of endovascular aneurysm
repair (EVAR) in the management of ruptured abdominal aortic
aneurysms (AAAs) are complex. This meta-analysis set out to
examine the current published data. Statistical analysis of the
overall hospital length of stay was not affected by heterogeneity or
bias and showed an 8.6-day reduction in those patients treated
with EVAR relative to open surgery. We suspect that most sur-
geons, patients, and hospital managers would be very pleased with
this outcome.
Although we accept that there may be some potential publi-
cation bias that resulted in us finding a 37.6% reduction in mortal-
ity and a 4-day reduction in the intensive treatment unit with
EVAR, these findings would be supported by the overall improve-
ment in length of stay. It is very difficult to see how these data
could be interpreted in such a negative way for the authors of the
letter to state “EVAR may be an option for symptomatic intact, but
not for ruptured AAAs.”
Many people have called for more randomized controlled
trials in this area, and some have even tried to run them. We believe
that trying to find out whether open repair or EVAR is better for
ruptured AAAs is asking the wrong question. A trial such as this
would exclude two important groups—those not stable enough
for EVAR and those who are not potentially fit enough to survive
an open repair. Those in the latter group are not EVAR II type
patients because they have ruptured AAAs and their immediate life
expectancy is very different. The question that should be asked
about EVAR is “What happens to the overall mortality of all
patients admitted to our institution with ruptured AAAs if we
include EVAR in our armamentarium?”
Centers committed to offering the best treatment for patients
with ruptured AAAs should provide a service that can offer EVAR
on a 24-hour basis.
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Carotid endarterectomy under local anesthesia may be
the treatment of choice for symptomatic carotid
artery stenosis
Two recent meta-analyses comparing carotid endarterectomy
(CEA) with carotid artery stenting (CAS) for symptomatic carotid
artery stenosis showed that CEA is superior to CAS with respect to
30-day stroke/death rates.1,2 The first meta-analysis included
2985 patients of whom 2646 (89%) were symptomatic and showed
a significant 38% increase in the odds of any stroke or death 30
days after treatment (odds ratio, 1.38; 95% confidence interval
[CI], 1.04-1.83; P  .024).1 The second meta-analysis included
3580 patients and showed that although patients undergoing CAS
had a higher risk of 30 day-stroke/death compared with patients
undergoing CEA (risk ratio [RR], 1.30; 95% CI, 1.01-1.67; P 
.05), the 30-day risk of stroke was not significantly different
between patients who underwent CAS vs CEA (RR, 1.27; 95% CI,
0.96-1.69).2 However, a subgroup analysis of trials enrolling only
symptomatic patients showed a higher risk of both 30-day stroke/
death (RR, 1.63; 95% CI, 1.18-2.25; P  .05) and 30-day stroke
rates (RR, 1.62; 95% CI, 1.13-2.31; P  .05) in CAS patients.2
The conclusion reached was that “surgical treatment still remains
the gold standard for treatment of patients with symptomatic
carotid artery stenosis, who do not have an increased risk.”1
In most of the trials included in the two meta-analyses, CEA
was performed under general anesthesia.1,2 A parameter that may
produce even better results for CEA compared with CAS (eg, even
lower 30-day stroke rates) is the performance of CEA under local
instead of general anesthesia. The use of local anesthesia for CEA
gives the surgeon the opportunity to directly assess the neurologic
status of the patient during the procedure. Moreover, CEA can be
safely performed under local anesthesia, even in high-risk patients.
A retrospective study of 365 procedures showed that the
performance of 200 CEAs with local anesthesia compared with
165 under general anesthesia was associated with significantly
lower stroke rates (1% vs 7.3%, respectively; P  .05), operation
time (104.5  24 vs 122  36 minutes, respectively; P  .0001),
cross-clamping time (14.6  4 vs 18.2  5 minutes, respectively;
P  .0001) and intraoperative shunt usage (8% vs 30.3%, respec-
tively; P  .0001).3 In addition, application of local instead of
general anesthesia was associated with decreased length of hospi-
talization (2.4  1.1 vs 4.1  1.9 days, respectively; P  .0001)
and associated costs ($885.71 $78.57 vs $1007.14 $135.71,
respectively; P  .0001).3 The superiority of local compared with
general anesthesia for CEA was supported in other similar trials, as
well.4,5
A drawback of these studies3-5 is their retrospective nature. A
prospective, multicenter randomized study, the General Anaes-
thetic versus Local Anaesthetic for carotid surgery (GALA) trial,
will soon report its results from 3529 patients undergoing CEA
under local vs general anesthesia.6 In the future, a similar, prospec-
tive, multicenter randomized trial comparing CAS with CEA per-
formed under local anesthesia may lead to the conclusion that “the
gold standard for symptomatic carotid artery stenosis” is indeed
surgical treatment, performed however, under local anesthesia.
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